Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Total 13F shares
-
8,090,280
-
Share change
-
-448,363
-
Total reported value
-
$2,264,622
-
Price per share
-
$0.28
-
Number of holders
-
13
-
Value change
-
-$123,934
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q4 2023
As of 31 Dec 2023,
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,090,280 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, JOHNSON & JOHNSON, 8VC GP I, LLC, RENAISSANCE TECHNOLOGIES LLC, MMCAP International Inc. SPC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Walleye Capital LLC, XTX Topco Ltd, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.